Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy - Discussion

被引：0
|
作者：
Levine, E
Loggie, BW
机构：
来源：
AMERICAN SURGEON | 1997年 / 63卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [41] Patterns of treatment failure in pediatric and young adult patients with Hodgkin's disease: Local disease control with combined-modality therapy
    Krasin, MJ
    Rai, SN
    Kun, LE
    Merchant, TE
    Metzger, ML
    Kaste, SC
    Howard, SC
    Hudson, MM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) : 8406 - 8413
  • [42] Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: Cure balanced against complications
    Koontz, BF
    Kirkpatrick, JP
    Clough, RW
    Prosnitz, RG
    Gockerman, JP
    Moore, JO
    Prosnitz, LR
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) : 605 - 611
  • [43] Treatment of pediatric malignant thymoma: Long-term remission in a 14-year-old boy with EBV-Associated thymic carcinoma by aggressive, combined modality treatment
    Niehues, T
    Harms, D
    Jurgens, H
    Gobel, U
    MEDICAL AND PEDIATRIC ONCOLOGY, 1996, 26 (06): : 419 - 424
  • [44] INTRAPERITONEAL THERAPY OF MALIGNANT ASCITES ASSOCIATED WITH CARCINOMA OF OVARY AND BREAST USING RADIOIODINATED MONOCLONAL ANTIBODY-2G3
    BUCKMAN, R
    DEANGELIS, C
    SHAW, P
    COVENS, A
    OSBORNE, R
    KERR, I
    REED, R
    MICHAELS, H
    WOO, M
    REILLY, R
    LAW, J
    BAUMAL, R
    GROVES, E
    MARKS, A
    GYNECOLOGIC ONCOLOGY, 1992, 47 (01) : 102 - 109
  • [45] COMBINED-MODALITY THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF ADVANCED NON HODGKINS LYMPHOMA AND SOLID TUMOR - THE KANAZAWA EXPERIENCE
    HARADA, M
    YOSHIDA, T
    FUNADA, H
    ISHINO, C
    KODO, H
    MORI, T
    MATSUE, K
    SHIOBARA, S
    ODAKA, K
    OHTAKE, S
    TESHIMA, H
    KONDO, K
    YAMAMURA, M
    NAKAO, S
    UEDA, M
    NAKAMURA, S
    HATTORI, K
    TRANSPLANTATION PROCEEDINGS, 1982, 14 (04) : 733 - 737
  • [46] Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: A review of the current literature and recommendations for treatment
    Bayman, Neil A.
    Blackhall, Fiona
    Jain, Pooja
    Lee, Lip
    Thatcher, Nick
    Faivre-Finn, Corinne
    CLINICAL LUNG CANCER, 2008, 9 (02) : 92 - 101
  • [47] COMBINED MODALITY THERAPY WITH RADIATION, TEMOZOLOMIDE, AND PI3-KINASE INHIBITORS FOR THE POTENTIAL TREATMENT OF MALIGNANT GLIOMAS
    Prasad, Gautam
    Mueller, Sabine
    Yang, Xiaodong
    James, C. David
    Berger, Mitchel
    Prados, Michael
    Haas-Kogan, Daphne
    NEURO-ONCOLOGY, 2008, 10 (05) : 792 - 793
  • [48] Current Status of Radiation Therapy and Combined-Modality Treatment for Bladder CancerAktueller Stand der Radiotherapie und der multimodalen organerhaltenden Therapie des Blasenkarzinoms
    Claus Rödel
    Strahlentherapie und Onkologie, 2004, 180 : 701 - 709
  • [49] SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation
    Yehong Bin
    Dong Lan
    Wenguang Bao
    Haiyan Yang
    Shengsheng Zhou
    Fengxiang Huang
    Man Wang
    Zhigang Peng
    Trials, 23
  • [50] SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation
    Bin, Yehong
    Lan, Dong
    Bao, Wenguang
    Yang, Haiyan
    Zhou, Shengsheng
    Huang, Fengxiang
    Wang, Man
    Peng, Zhigang
    TRIALS, 2022, 23 (01)
12345